{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:54:00Z","timestamp":1760298840037},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Krebsliga Zentralschweiz"},{"DOI":"10.13039\/501100004201","name":"Oncosuisse","doi-asserted-by":"crossref","award":["KLS-2867-08-2011"],"award-info":[{"award-number":["KLS-2867-08-2011"]}],"id":[{"id":"10.13039\/501100004201","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ejcancer.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ejca.2013.11.018","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T14:48:47Z","timestamp":1386082127000},"page":"731-738","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules"],"prefix":"10.1016","volume":"50","author":[{"given":"Luca","family":"Quagliata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariacarla","family":"Andreozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Tornillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzanna","family":"Makowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus H.","family":"Heim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Heinimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Piscuoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi Maria","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2013.11.018_b0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ng0802-339","article-title":"Molecular pathogenesis of human hepatocellular carcinoma","volume":"31","author":"Thorgeirsson","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejca.2013.11.018_b0010","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2013.11.018_b0015","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3748\/wjg.14.4300","article-title":"Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis","volume":"14","author":"Gomaa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejca.2013.11.018_b0020","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2013.11.018_b0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000218339","article-title":"Hepatocellular carcinoma \u2013 epidemiological trends and risk factors","volume":"27","author":"Schutte","year":"2009","journal-title":"Dig Dis"},{"key":"10.1016\/j.ejca.2013.11.018_b0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2004.12.009","article-title":"Epidemiology of hepatocellular carcinoma","volume":"9","author":"Bosch","year":"2005","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ejca.2013.11.018_b0035","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cld.2012.08.011","article-title":"Liver cancer and alcohol","volume":"16","author":"Grewal","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"12","key":"10.1016\/j.ejca.2013.11.018_b0040","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cgh.2012.08.011","article-title":"Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies","volume":"10","author":"Mair","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2013.11.018_b0045","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejca.2013.11.018_b0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0031-1276646","article-title":"Genetics of hepatobiliary carcinogenesis","volume":"31","author":"Nault","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ejca.2013.11.018_b0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0030-1247131","article-title":"Molecular classification and novel targets in hepatocellular carcinoma: recent advancements","volume":"30","author":"Hoshida","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ejca.2013.11.018_b0060","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2009.12.034","article-title":"Cancer gene discovery in hepatocellular carcinoma","volume":"52","author":"Zender","year":"2010","journal-title":"J Hepatol"},{"issue":"1618\u20131628","key":"10.1016\/j.ejca.2013.11.018_b0065","first-page":"e1616","article-title":"MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a","volume":"140","author":"Toffanin","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2013.11.018_b0070","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ijc.26063","article-title":"Oncogenetic tree modeling of human hepatocarcinogenesis","volume":"130","author":"Longerich","year":"2012","journal-title":"Int J Cancer"},{"issue":"957\u2013966","key":"10.1016\/j.ejca.2013.11.018_b0075","first-page":"e912","article-title":"Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival","volume":"142","author":"Roessler","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2013.11.018_b0080","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH706>3.0.CO;2-O","article-title":"Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas","volume":"192","author":"Tornillo","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2013.11.018_b0085","first-page":"5368","article-title":"Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer","volume":"52","author":"Emi","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.11.018_b0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2407-8-187","article-title":"Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level","volume":"8","author":"Macartney-Coxson","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2013.11.018_b0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-065X.2009.00829.x","article-title":"The T-cell-specific adapter protein family: TSAd, ALX, and SH2D4A\/SH2D4B","volume":"232","author":"Lapinski","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ejca.2013.11.018_b0100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.5483\/BMBRep.2009.42.8.516","article-title":"SH2D4A regulates cell proliferation via the ERalpha\/PLC-gamma\/PKC pathway","volume":"42","author":"Li","year":"2009","journal-title":"BMB Rep"},{"key":"10.1016\/j.ejca.2013.11.018_b0105","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.4049\/jimmunol.181.3.2019","article-title":"Genetic analysis of SH2D4A, a novel adapter protein related to T cell-specific adapter and adapter protein in lymphocytes of unknown function, reveals a redundant function in T cells","volume":"181","author":"Lapinski","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ejca.2013.11.018_b0110","doi-asserted-by":"crossref","first-page":"G1067","DOI":"10.1152\/ajpgi.00234.2005","article-title":"Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon","volume":"290","author":"Dydensborg","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ejca.2013.11.018_b0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ejca.2013.11.018_b0120","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1309\/HCQWPWD50XHD2DW6","article-title":"Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples","volume":"129","author":"Baumhoer","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejca.2013.11.018_b0125","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/modpathol.2008.117","article-title":"Differential diagnostic and functional role of the multi-marker phenotype CDX2\/CK20\/CK7 in colorectal cancer stratified by mismatch repair status","volume":"21","author":"Lugli","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2013.11.018_b0130","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"Allred","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2013.11.018_b0135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/jclinpath-2011-200043","article-title":"Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater","volume":"65","author":"Piscuoglio","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejca.2013.11.018_b0140","doi-asserted-by":"crossref","unstructured":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998;28:751\u201355.","DOI":"10.1002\/hep.510280322"},{"issue":"Suppl. 4","key":"10.1016\/j.ejca.2013.11.018_b0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.2010-S4-34","article-title":"Current approaches to the treatment of early hepatocellular carcinoma","volume":"15","author":"Ye","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.ejca.2013.11.018_b0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00042737-200505000-00005","article-title":"Surgical therapy of hepatocellular carcinoma","volume":"17","author":"McCormack","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2013.11.018_b0155","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2013.11.018_b0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003495-200969020-00006","article-title":"Sorafenib: a review of its use in advanced hepatocellular carcinoma","volume":"69","author":"Keating","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ejca.2013.11.018_b0165","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1038\/sj.onc.1202648","article-title":"Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma","volume":"18","author":"Pineau","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2013.11.018_b0170","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1053\/jhep.2000.18425","article-title":"Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies","volume":"32","author":"Maggioni","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.ejca.2013.11.018_b0175","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/labinvest.3780449","article-title":"Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma","volume":"82","author":"Tornillo","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.ejca.2013.11.018_b0180","first-page":"3389","article-title":"Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma","volume":"9","author":"Matsuda","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2013.11.018_b0185","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/path.1946","article-title":"Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?","volume":"208","author":"Denk","year":"2006","journal-title":"J Pathol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913010137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913010137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T14:58:49Z","timestamp":1539010729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804913010137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0959804913010137"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2013.11.018","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2013.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}